Sino Biopharmaceutical Says Two Drugs Receive Breakthrough Therapy Designation
Sino Biopharmaceutical said TQ-A3334 and TQA3605 obtained breakthrough therapy designation.
Sino Biopharmaceutical said TQ-A3334 and TQA3605 obtained breakthrough therapy designation.